Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG.

Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A.

Prostate. 2017 May;77(6):647-653. doi: 10.1002/pros.23312. Epub 2017 Jan 19.

PMID:
28102015
2.

Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.

Ahearn TU, Tchrakian N, Wilson KM, Lis R, Nuttall E, Sesso HD, Loda M, Giovannucci E, Mucci LA, Finn S, Shui IM.

J Clin Endocrinol Metab. 2016 Jun;101(6):2520-7. doi: 10.1210/jc.2016-1082. Epub 2016 Apr 26.

PMID:
27115058
3.

Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.

Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A.

Br J Cancer. 2016 Apr 12;114(8):939-44. doi: 10.1038/bjc.2016.61. Epub 2016 Mar 17.

4.

Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.

Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA.

Am J Clin Nutr. 2016 Mar;103(3):851-60. doi: 10.3945/ajcn.115.118703. Epub 2016 Jan 27.

5.

Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.

Mehra R, Udager AM, Ahearn TU, Cao X, Feng FY, Loda M, Petimar JS, Kantoff P, Mucci LA, Chinnaiyan AM.

Eur Urol. 2016 Oct;70(4):549-552. doi: 10.1016/j.eururo.2015.12.003. Epub 2015 Dec 24.

PMID:
26724257
6.

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL.

J Natl Cancer Inst. 2015 Nov 27;108(2). pii: djv346. doi: 10.1093/jnci/djv346. Print 2016 Feb.

7.

The expanding role of body mass in active surveillance for prostate cancer.

Ahearn TU, Shui IM, Giovannucci EL.

Eur Urol. 2014 Nov;66(5):849-50. doi: 10.1016/j.eururo.2014.06.043. Epub 2014 Jul 15. No abstract available.

PMID:
25037639
8.

Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms.

Tu H, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Seabrook ME, Bostick RM.

Mol Carcinog. 2015 Sep;54(9):821-30. doi: 10.1002/mc.22152. Epub 2014 Apr 9.

PMID:
24719252
9.

Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial.

Tu H, Flanders WD, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Long Q, Rutherford RE, Bostick RM.

Mol Carcinog. 2015 Apr;54(4):270-80. doi: 10.1002/mc.22096. Epub 2013 Oct 26.

10.

Effects of calcium and vitamin D supplementation on crypt morphology in normal colon mucosa: A randomized clinical trial.

Shen H, Ahearn TU, Bostick RM.

Mol Carcinog. 2015 Mar;54(3):242-7. doi: 10.1002/mc.22090. Epub 2013 Sep 24.

11.

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients.

Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bostick RM.

Cancer Prev Res (Phila). 2012 Oct;5(10):1247-56. doi: 10.1158/1940-6207.CAPR-12-0292. Epub 2012 Sep 10.

12.

Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms.

Ahearn TU, Shaukat A, Flanders WD, Seabrook ME, Bostick RM.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):969-79. doi: 10.1158/1055-9965.EPI-12-0126. Epub 2012 Apr 26.

13.

Effects of vitamin D3 and calcium supplementation on serum levels of tocopherols, retinol, and specific vitamin D metabolites.

Chai W, Bostick RM, Ahearn TU, Franke AA, Custer LJ, Cooney RV.

Nutr Cancer. 2012;64(1):57-64. doi: 10.1080/01635581.2012.630552. Epub 2011 Dec 9.

14.

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients.

Ahearn TU, McCullough ML, Flanders WD, Long Q, Sidelnikov E, Fedirko V, Daniel CR, Rutherford RE, Shaukat A, Bostick RM.

Cancer Res. 2011 Jan 15;71(2):413-23. doi: 10.1158/0008-5472.CAN-10-1560. Epub 2010 Nov 17.

15.

Detecting and quantifying biomarkers of risk for colorectal cancer using quantum dots and novel image analysis algorithms.

Bostick RM, Kong KY, Ahearn TU, Chaudry Q, Cohen V, Wang MD.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:3313-6.

PMID:
17947019

Supplemental Content

Loading ...
Support Center